Further growth expected in Monksland biopharma cluster

The IDA believes there will be significant growth in the existing worldclass hub for biopharmaceutical manufacture in Monksland in the coming years.

The State agency said it “anticipates that significant new investment will be attracted to the location in the period 2024-2030...”

It said the expansion of existing operations and the arrival of new greenfield investment to the area would facilitate the sustainable growth of the Athlone area.

It also noted the Monksland industrial zone had transitioned in recent years to a “world class hub for biopharmaceutical manufacture including research and development”.

The comments were made as part of a public consultation submission made to Westmeath and Roscommon county councils on the issues paper for the local authorities' forthcoming joint Athlone Urban Area Plan for 2024 to 2030.

The IDA said the plan should continue to enable this growth.

Continued on page 2